Your browser doesn't support javascript.
loading
Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain.
Ogata, Aya; Yamada, Takashi; Hattori, Saori; Ikenuma, Hiroshi; Abe, Junichiro; Tada, Mari; Ichise, Masanori; Suzuki, Masaaki; Ito, Kengo; Kato, Takashi; Amaike, Kazuma; Hirota, Tsuyoshi; Kakita, Akiyoshi; Itami, Kenichiro; Kimura, Yasuyuki.
Afiliación
  • Ogata A; Department of Pharmacy, Faculty of Pharmacy, Gifu University of Medical Science (GUMS), Kani, Japan; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan. Electronic address:
  • Yamada T; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Hattori S; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Ikenuma H; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Abe J; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Tada M; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Ichise M; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Suzuki M; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Ito K; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Kato T; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan.
  • Amaike K; Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Hirota T; Institute of Transformative Bio-Molecules (WPI-ITbM) Nagoya University, Nagoya, Japan.
  • Kakita A; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Itami K; Graduate School of Science, Nagoya University, Nagoya, Japan; Institute of Transformative Bio-Molecules (WPI-ITbM) Nagoya University, Nagoya, Japan.
  • Kimura Y; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan. Electronic address: yazkim@ncgg.go.jp.
Bioorg Med Chem Lett ; 90: 129327, 2023 06 15.
Article en En | MEDLINE | ID: mdl-37187253
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinasa de la Caseína II / Enfermedad de Alzheimer Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinasa de la Caseína II / Enfermedad de Alzheimer Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2023 Tipo del documento: Article